Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Adherence to adding inhaled corticosteroids to rescue therapy in a pragmatic trial with adults with asthma: A pilot study.

Cardet JC, Busse PJ, Carroll JK, Casale TB, Coyne-Beasley T, Dixon-Williams S, Fagan M, Forth VE, Fuhlbrigge AL, Hernandez ML, Kaelber D, Kaplan B, Lorenzi M, Madison S, Maher NE, Majewski K, Manning B, McKee MD, Nazario S, Pace WD, Pencina MJ, Rand CS, Rodriguez-Louis J, She L, Shields J, Teng JE, Wechsler ME, Wisnivesky JP, Yawn BP, Israel E.

Ann Allergy Asthma Immunol. 2020 Jan 8. pii: S1081-1206(20)30002-8. doi: 10.1016/j.anai.2019.12.027. [Epub ahead of print]

PMID:
31923550
2.

An expert consensus framework for asthma remission as a treatment goal.

Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, Szefler SJ, Woodruff PG, de Giorgio-Miller A, Trudo F, Fageras M, Ambrose CS.

J Allergy Clin Immunol. 2019 Dec 19. pii: S0091-6749(19)31708-7. doi: 10.1016/j.jaci.2019.12.006. [Epub ahead of print]

3.

Real-World Assessment of Asthma Control and Severity in Children, Adolescents, and Adults with Asthma: Relationships to Care Settings and Comorbidities.

Nyenhuis SM, Akkoyun E, Liu L, Schatz M, Casale TB.

J Allergy Clin Immunol Pract. 2019 Nov 7. pii: S2213-2198(19)30923-7. doi: 10.1016/j.jaip.2019.10.032. [Epub ahead of print]

PMID:
31707065
4.

Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics.

Casale TB, Aalbers R, Bleecker ER, Meltzer EO, Zaremba-Pechmann L, de la Hoz A, Kerstjens HAM.

Respir Med. 2019 Oct - Nov;158:97-109. doi: 10.1016/j.rmed.2019.09.014. Epub 2019 Sep 30.

PMID:
31654891
5.

Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma.

FitzGerald JM, Buhl R, Casale TB, Jugovic B, Zaremba-Pechmann L, Halpin DMG.

Eur Respir J. 2020 Jan 2;55(1). pii: 1900964. doi: 10.1183/13993003.00964-2019. Print 2020 Jan. No abstract available.

PMID:
31619471
6.

Biologics, Clinical Context, and the Asthmas.

Casale TB, Israel E.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1437-1439. doi: 10.1016/j.jaip.2019.03.012. No abstract available.

PMID:
31076059
7.

Impact of omalizumab on patient-reported outcomes in chronic idiopathic urticaria: Results from a randomized study (XTEND-CIU).

Casale TB, Murphy TR, Holden M, Rajput Y, Yoo B, Bernstein JA.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2487-2490.e1. doi: 10.1016/j.jaip.2019.04.020. Epub 2019 Apr 26. No abstract available.

8.

Reply.

Cardet JC, Casale TB.

J Allergy Clin Immunol. 2019 Jun;143(6):2336. doi: 10.1016/j.jaci.2019.03.014. Epub 2019 Apr 20. No abstract available.

PMID:
31014897
9.

Tiotropium reduces airflow obstruction in asthma patients, independent of body mass index.

Khurana S, Paggiaro P, Buhl R, Bernstein JA, Haddon J, Unseld A, Engel M, Casale TB, Dixon AE.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2425-2428.e7. doi: 10.1016/j.jaip.2019.03.007. Epub 2019 Mar 19. No abstract available.

10.

Validation of Patient-Reported Outcomes for Clinical Trials in Allergic Rhinitis: A Systematic Review.

Calderón MA, Casale TB, Demoly P.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1450-1461.e6. doi: 10.1016/j.jaip.2019.01.015. Epub 2019 Feb 20. Review.

PMID:
30797777
11.

New insights into the utility of omalizumab.

Cardet JC, Casale TB.

J Allergy Clin Immunol. 2019 Mar;143(3):923-926.e1. doi: 10.1016/j.jaci.2019.01.016. Epub 2019 Jan 26. No abstract available.

12.

Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO.

Hanania NA, Chipps BE, Griffin NM, Yoo B, Iqbal A, Casale TB.

J Allergy Clin Immunol. 2019 Apr;143(4):1629-1633.e2. doi: 10.1016/j.jaci.2018.11.032. Epub 2018 Dec 18. No abstract available.

13.

ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project.

Bosnic-Anticevich S, Costa E, Menditto E, Lourenço O, Novellino E, Bialek S, Briedis V, Buonaiuto R, Chrystyn H, Cvetkovski B, Di Capua S, Kritikos V, Mair A, Orlando V, Paulino E, Salimäki J, Söderlund R, Tan R, Williams DM, Wroczynski P, Agache I, Ansotegui IJ, Anto JM, Bedbrook A, Bachert C, Bewick M, Bindslev-Jensen C, Brozek JL, Canonica GW, Cardona V, Carr W, Casale TB, Chavannes NH, Correia de Sousa J, Cruz AA, Czarlewski W, De Carlo G, Demoly P, Devillier P, Dykewicz MS, Gaga M, El-Gamal Y, Fonseca J, Fokkens WJ, Guzmán MA, Haahtela T, Hellings PW, Illario M, Ivancevich JC, Just J, Kaidashev I, Khaitov M, Khaltaev N, Keil T, Klimek L, Kowalski ML, Kuna P, Kvedariene V, Larenas-Linnemann DE, Laune D, Le LTT, Lodrup Carlsen KC, Mahboub B, Maier D, Malva J, Manning PJ, Morais-Almeida M, Mösges R, Mullol J, Münter L, Murray R, Naclerio R, Namazova-Baranova L, Nekam K, Nyembue TD, Okubo K, O'Hehir RE, Ohta K, Okamoto Y, Onorato GL, Palkonen S, Panzner P, Papadopoulos NG, Park HS, Pawankar R, Pfaar O, Phillips J, Plavec D, Popov TA, Potter PC, Prokopakis EP, Roller-Wirnsberger RE, Rottem M, Ryan D, Samolinski B, Sanchez-Borges M, Schunemann HJ, Sheikh A, Sisul JC, Somekh D, Stellato C, To T, Todo-Bom AM, Tomazic PV, Toppila-Salmi S, Valero A, Valiulis A, Valovirta E, Ventura MT, Wagenmann M, Wallace D, Waserman S, Wickman M, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zidarn M, Zuberbier T, Bousquet J.

Allergy. 2019 Jul;74(7):1219-1236. doi: 10.1111/all.13701. Epub 2019 Apr 30. Review.

PMID:
30565275
14.

Harmonization of Terminology for Tolerated and Reactive Dose in Food Allergy Immunotherapy.

Casale TB, Haselkorn T, Ciaccio CE, Sriaroon P, Chipps BE.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):389-392. doi: 10.1016/j.jaip.2018.12.008. Epub 2018 Dec 14.

15.

Real-world attitudes among allergists/immunologists regarding oral immunotherapy and preferred terminology.

Chipps BE, Ciaccio CE, Rosén K, Haselkorn T, Zigmont E, Casale TB.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):721-723.e9. doi: 10.1016/j.jaip.2018.12.009. Epub 2018 Dec 14. No abstract available.

16.

AR101 Oral Immunotherapy for Peanut Allergy.

PALISADE Group of Clinical Investigators, Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, Jones SM, Shreffler WG, Marcantonio A, Zawadzki R, Sher L, Carr WW, Fineman S, Greos L, Rachid R, Ibáñez MD, Tilles S, Assa’ad AH, Nilsson C, Rupp N, Welch MJ, Sussman G, Chinthrajah S, Blumchen K, Sher E, Spergel JM, Leickly FE, Zielen S, Wang J, Sanders GM, Wood RA, Cheema A, Bindslev-Jensen C, Leonard S, Kachru R, Johnston DT, Hampel FC Jr, Kim EH, Anagnostou A, Pongracic JA, Ben-Shoshan M, Sharma HP, Stillerman A, Windom HH, Yang WH, Muraro A, Zubeldia JM, Sharma V, Dorsey MJ, Chong HJ, Ohayon J, Bird JA, Carr TF, Siri D, Fernández-Rivas M, Jeong DK, Fleischer DM, Lieberman JA, Dubois AEJ, Tsoumani M, Ciaccio CE, Portnoy JM, Mansfield LE, Fritz SB, Lanser BJ, Matz J, Oude Elberink HNG, Varshney P, Dilly SG, Adelman DC, Burks AW.

N Engl J Med. 2018 Nov 22;379(21):1991-2001. doi: 10.1056/NEJMoa1812856. Epub 2018 Nov 18.

PMID:
30449234
17.

Can Xolair Be Used in Nonallergic Asthmatic?

Ledford DK, Casale TB.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2170. doi: 10.1016/j.jaip.2018.08.005. No abstract available.

PMID:
30390909
18.

Potential new targets for drug development in severe asthma.

Zhu L, Ciaccio CE, Casale TB.

World Allergy Organ J. 2018 Oct 25;11(1):30. doi: 10.1186/s40413-018-0208-1. eCollection 2018. Review.

19.

American Academy of Allergy, Asthma and Immunology response to the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of Urticaria 2017 revision.

Wood RA, Khan DA, Lang DM, Fasano MB, Peden DB, Busse PJ, Carter MC, Demain JG, Dinakar C, Grayson MH, Markovics SB, Sicherer SH, Stone KD, Sullivan KE, Williams PV, Fleisher TA, Casale TB.

Allergy. 2019 Feb;74(2):411-413. doi: 10.1111/all.13636. Epub 2018 Dec 12. No abstract available.

PMID:
30338538
20.

Upregulated P-Rex1 exacerbates human airway smooth muscle hyperplasia in asthma.

Huang Y, Xie Y, Jiang H, Abel PW, Panettieri RA Jr, Casale TB, Tu Y.

J Allergy Clin Immunol. 2019 Feb;143(2):778-781.e5. doi: 10.1016/j.jaci.2018.09.020. Epub 2018 Oct 10. No abstract available.

PMID:
30312708
21.

The challenge of choosing the correct biologic for the correct asthma patient.

Sriaroon P, Casale TB.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):385-386. doi: 10.1016/j.anai.2018.08.012. No abstract available.

PMID:
30290891
22.

Effects of Exposure to New Car Interiors in Patients With Asthma and Allergic Rhinitis.

Pepper AN, Bulkhi A, Smith CR, Colli M, Bergmann KC, Zuberbier T, Casale TB.

Allergy Rhinol (Providence). 2018 Sep 18;9:2152656718800060. doi: 10.1177/2152656718800060. eCollection 2018 Jan-Dec.

23.

Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis.

Casale TB, Pacou M, Mesana L, Farge G, Sun SX, Castro M.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):122-130.e1. doi: 10.1016/j.jaip.2018.08.036. Epub 2018 Sep 11.

PMID:
30217529
24.

Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria.

Deza G, Ricketti PA, Giménez-Arnau AM, Casale TB.

J Allergy Clin Immunol Pract. 2018 Jul - Aug;6(4):1108-1117. doi: 10.1016/j.jaip.2018.02.024. Review.

PMID:
30033912
25.

Biological therapies for eosinophilic asthma.

Patel SS, Casale TB, Cardet JC.

Expert Opin Biol Ther. 2018 Jul;18(7):747-754. doi: 10.1080/14712598.2018.1492540. Epub 2018 Jul 4. Review.

26.

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study.

Casale TB, Luskin AT, Busse W, Zeiger RS, Trzaskoma B, Yang M, Griffin NM, Chipps BE.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):156-164.e1. doi: 10.1016/j.jaip.2018.04.043. Epub 2018 May 22.

27.

The importance of allergic disease in public health: an iCAALL statement.

Sánchez-Borges M, Martin BL, Muraro AM, Wood RA, Agache IO, Ansotegui IJ, Casale TB, Fleisher TA, Hellings PW, Papadopoulos NG, Peden DB, Sublett JL, Tilles SA, Rosenwasser L.

World Allergy Organ J. 2018 Apr 27;11(1):8. doi: 10.1186/s40413-018-0187-2. eCollection 2018. No abstract available.

28.

Uses of biologics in allergic diseases: What to choose and when.

Saco TV, Pepper A, Casale TB.

Ann Allergy Asthma Immunol. 2018 Apr;120(4):357-366. doi: 10.1016/j.anai.2018.02.029. Epub 2018 Feb 27. Review. No abstract available.

PMID:
29499367
29.

Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects: Rome, Italy/Vatican City. 27-29 April 2017.

Traina G, Valluzzi RL, Fierro V, Riccardi C, Artesani MC, De Vuono A, Fiocchi A, Martelli AG, Ríos LA, Alcocer CR, Navarrete E, Del Rio Navarro BE, Gonzalez V, Velasco B, Perez Aviles HJ, Fernandez RJ, Pozo FC, Farhan AJ, Arshad H, Hussain A, Sharikadze O, Okhotnikova O, Alcover J, Rodriguez D, Pineda F, Dalal I, Weinbrand-Goichberg J, Benor S, Rottem M, Kivity S, Sato S, Yanagida N, Ebisawa M, Umanets T, Pineda F, Antipkin Y, Barzylovich V, Lapshyn V, Umanets T, Umanets M, Yuriev S, Pineda F, Rodriguez D, Alcover J, Bekir S, Pincock T, Vieira Hernandez A, Capriles Hulett A, Sánchez Borges M, Fabiano F, Albarran C, Goyal R, Gupta S, Gaurav G, Luskin AT, Griffin NM, Wagelie-Steffen A, Trzaskoma BL, Limb SL, Busse WW, Zeiger RS, Gonzalez-Reyes E, Casale TB, Chipps BE, Sugizaki C, Goto F, Sato S, Yanagida N, Ebisawa M, Yamaide A, Mitsunaga K, Tomiita M, Hoshioka A, Shimojo N, Pop LL, Ciucǎ IM, Tǎmaş L, Lazarescu M, Pienar C, Yamaide F, Fikri B, Sato H, Shimojo N, Okishima N, Kobayashi M, Takai M, Nishigata K, Yoda R, Oana YT, Kajiwara C, Shimodaira M, Suzuki T, Iizawa H, Kamijo K, Karmakar B, Bhattacharya SG, Blohlávková S, Kopelentová E, Víšek P, Štádler J, Šetinová I, Novobílská J, Lundelin K, Salminen S, Isolauri E, Pitt T, Flanders T, Peñalver M, Martínez P, Lluch M, Malet A, Nam YH, Jin HJ, Lee SK, Kulalert P, Sritipsukho P, Pathumanond J, Baynova K, Labella M, De Aramburu T, Prados M, Haanpää L, Aarnio J, Nermes M, Af Ursin P, Kaljonen A, Isolauri E, Bala N, Bhagwat K, Hindley J, Chapman M, Baalasubramanian S, Besednjak-Kocijančič L, SenGupta K, Bhattacharya SG, Chipps BE, Antonova E, Kong AM, Iqbal A, Teague WG, Chipps BE, Antonova E, Trzaskoma B, Ortiz B, Paknis B, Iqbal A, Rosen K, Szefler S, Alblooshi A, Al-Hammadi S, Vega A, Gutiérrez-Rivas R, Alonso AM, Beitia JM, Belén Mateo M, Cárdenas R, García-Domínguez JJ, Pitchon Dos Reis R, Gonçalves Alvim C, Andrade C, Reis A, Ribeiro H, Panaitescu Bunu C, Marusciac L, Paralescu S, Tamas P, Panitescu Bunu C, Marusciac L, Paralescu S, Tamas P, Martí Guadaño E, Escobar Bolaños C, Martí José N, Pau Casanovas P, Biarnés Rib G, Castells M, de Vicente Jiménez T, Mennini M, Riccardi C, De Angelis P, Rea F, Malamisura M, Tambucci R, Fiocchi A, Dall'Oglio L, Mennini M, Del Chierico F, Napolitano T, Reddel S, Vernocchi P, D'Ambrosio A, Putignani L, Artesani MC, Dahdah L, Fierro V, Banzato C, Echeverría Zudaire LA, Plaza AM, Bosque García M, Íbero M, Mazzina O, Fierro V, Marzano V, Riccardi C, Mazzina O, Dahdah L, Mennini M, Artesani MC, Mazzina O, Pecora V, Koch P, Valluzzi RL, Fierro V, Fiocchi A, Pecora V, Valentini D, Mennini M, Dahdah L, Mazzina O, Santamaria F, Valluzzi R, Mukherjee A, Kandhare A, Bodhankar S.

World Allergy Organ J. 2017 Nov 16;10(Suppl 2):39. doi: 10.1186/s40413-017-0170-3. eCollection 2017. No abstract available.

30.

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.

Luskin AT, Chipps BE, Casale TB, Griffin NM.

Ann Allergy Asthma Immunol. 2018 May;120(5):549-550. doi: 10.1016/j.anai.2018.01.034. Epub 2018 Feb 5. No abstract available.

PMID:
29421314
31.

Allergic rhinitis management: what's next?

Tabatabaian F, Casale TB.

Expert Rev Clin Immunol. 2018 Mar;14(3):191-196. doi: 10.1080/1744666X.2018.1438270. Epub 2018 Feb 15. Review.

PMID:
29406839
32.

Efficacy of tiotropium in adults with moderate asthma, by leukotriene receptor antagonist use at baseline.

Hashimoto S, Casale TB, Engel M, Moroni-Zentgraf P, Bour LJ, Kerstjens HAM.

Allergol Int. 2018 Jul;67(3):411-413. doi: 10.1016/j.alit.2017.12.002. Epub 2018 Feb 15. No abstract available.

33.

Zika virus: An emerging infectious disease with serious perinatal and neurologic complications.

Casale TB, Teng MN, Morano JP, Unnasch T, Lockwood CJ.

J Allergy Clin Immunol. 2018 Feb;141(2):482-490. doi: 10.1016/j.jaci.2017.11.029. Epub 2017 Dec 19. Review.

PMID:
29273403
34.

Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype.

Casale TB, Bateman ED, Vandewalker M, Virchow JC, Schmidt H, Engel M, Moroni-Zentgraf P, Kerstjens HAM.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):923-935.e9. doi: 10.1016/j.jaip.2017.08.037. Epub 2017 Nov 22.

35.

The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria.

Maurer M, Kaplan A, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Casale TB.

J Allergy Clin Immunol. 2018 Mar;141(3):1138-1139.e7. doi: 10.1016/j.jaci.2017.10.018. Epub 2017 Nov 10. No abstract available.

PMID:
29132956
36.

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO.

Chipps BE, Zeiger RS, Luskin AT, Busse WW, Trzaskoma BL, Antonova EN, Pazwash H, Limb SL, Solari PG, Griffin NM, Casale TB.

Ann Allergy Asthma Immunol. 2017 Dec;119(6):524-532.e2. doi: 10.1016/j.anai.2017.09.056. Epub 2017 Oct 18.

37.

[ARIA 2016 executive summary: Integrated care pathways for predictive medicine throughout the life cycle in Argentina].

Ivancevich JC, Neffen H, Zernotti ME, Asayag E, Blua A, Cicerán A, Jares EJ, Lavrut AJ, Máspero JF, Agache I, Bachert C, Bedbrook A, Canonica GW, Casale TB, Cruz ÁA, Fokkens WJ, Hellings PW, Samolinski B, Bousquet J.

Rev Alerg Mex. 2017 Jul-Sep;64(3):298-308. Spanish.

PMID:
29046028
38.

Omalizumab response in patients with chronic idiopathic urticaria: Insights from the XTEND-CIU study.

Casale TB, Win PH, Bernstein JA, Rosén K, Holden M, Iqbal A, Trzaskoma BL, Yang M, Antonova EN, Murphy T, Scarupa MD, Sofen H, Kaplan A.

J Am Acad Dermatol. 2018 Apr;78(4):793-795. doi: 10.1016/j.jaad.2017.10.010. Epub 2017 Oct 14. No abstract available.

39.

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.

Casale TB, Chipps BE, Rosén K, Trzaskoma B, Haselkorn T, Omachi TA, Greenberg S, Hanania NA.

Allergy. 2018 Feb;73(2):490-497. doi: 10.1111/all.13302. Epub 2017 Sep 23.

40.

Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials.

Casale TB, Cox LS, Wahn U, Golden DBK, Bons B, Didier A.

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1717-1727.e1. doi: 10.1016/j.jaip.2017.04.020. Epub 2017 Jul 19.

PMID:
28734858
41.

Nasal Carbon Dioxide Used As Needed in the Symptomatic Treatment of Seasonal Allergic Rhinitis.

Casale TB, Onder RF, Berkowitz RB, Korenblat PE.

J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):183-189. doi: 10.1016/j.jaip.2017.05.028. Epub 2017 Jul 11.

PMID:
28705451
42.

Biologic Therapy and Novel Molecular Targets of Severe Asthma.

Pepper AN, Renz H, Casale TB, Garn H.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):909-916. doi: 10.1016/j.jaip.2017.04.038. Review.

PMID:
28689841
43.

Biologics and biomarkers for asthma, urticaria, and nasal polyposis.

Casale TB.

J Allergy Clin Immunol. 2017 May;139(5):1411-1421. doi: 10.1016/j.jaci.2017.03.006. Review.

PMID:
28477720
44.

Effect of intranasal corticosteroids on allergic airway disease in asthma.

Dixon AE, Castro M, Gerald LB, Holbrook JT, Henderson RJ, Casale TB, Irvin CG, Black K, Wise RA, Sugar EA; American Lung Association Airways Clinical Research Centers' Writing Committee.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1125-1128.e3. doi: 10.1016/j.jaip.2017.02.022. Epub 2017 Apr 7. No abstract available.

45.

Biologic and New Therapies in Asthma.

Tabatabaian F, Ledford DK, Casale TB.

Immunol Allergy Clin North Am. 2017 May;37(2):329-343. doi: 10.1016/j.iac.2017.01.007. Review.

PMID:
28366480
46.

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles.

Nelson HS, Calderon MA, Bernstein DI, Casale TB, Durham SR, Andersen JS, Esch R, Cox LS, Nolte H.

Curr Allergy Asthma Rep. 2017 Mar;17(3):18. doi: 10.1007/s11882-017-0687-0. Review.

PMID:
28293909
47.

Investigational new drugs for allergic rhinitis.

Ricketti PA, Alandijani S, Lin CH, Casale TB.

Expert Opin Investig Drugs. 2017 Mar;26(3):279-292. doi: 10.1080/13543784.2017.1290079. Review.

PMID:
28141955
48.

The Potential Role of Allergen Immunotherapy in Stepping Down Asthma Treatment.

Demoly P, Makatsori M, Casale TB, Calderon MA.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):640-648. doi: 10.1016/j.jaip.2016.11.024. Epub 2016 Dec 30. Review.

PMID:
28042004
49.

Biologics in Chronic Urticaria.

Bulkhi A, Cooke AJ, Casale TB.

Immunol Allergy Clin North Am. 2017 Feb;37(1):95-112. doi: 10.1016/j.iac.2016.08.004. Epub 2016 Oct 28. Review.

PMID:
27886913
50.

Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.

Nolte H, Casale TB, Lockey RF, Fogh BS, Kaur A, Lu S, Nelson HS.

J Allergy Clin Immunol Pract. 2017 Jan - Feb;5(1):84-89.e3. doi: 10.1016/j.jaip.2016.08.017. Epub 2016 Nov 9.

PMID:
27838323

Supplemental Content

Loading ...
Support Center